These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 5385252)
21. Diamino diphenyl sulfone in leprosy chemoprophylaxis. Sharma DR Indian Pediatr; 1971 May; 8(5):215-6. PubMed ID: 5095253 [No Abstract] [Full Text] [Related]
22. Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):161-72. PubMed ID: 1522358 [TBL] [Abstract][Full Text] [Related]
23. Self-administered dapsone compliance of leprosy patients in eastern Nepal. van Trier YD; de Soldenhoff R Lepr Rev; 1991 Mar; 62(1):53-7. PubMed ID: 2034026 [TBL] [Abstract][Full Text] [Related]
29. Drug resistance in Nepali leprosy patients. Butlin CR; Neupane KD; Failbus SS; Morgan A; Britton WJ Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):136-41. PubMed ID: 8690972 [TBL] [Abstract][Full Text] [Related]
30. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related]
33. The leprosy problem in the South Pacific. Crawford C N Z Med J; 2014 May; 127(1394):91-3. PubMed ID: 24929576 [No Abstract] [Full Text] [Related]
34. Utilization of medical agencies and treatment compliance by urban (Madras) leprosy patients. Kumar A; Sivaprasad N; Anbalagan M; Thangavel N; Durgambal K Lepr India; 1983 Apr; 55(2):322-32. PubMed ID: 6632787 [TBL] [Abstract][Full Text] [Related]
35. A study of 922 bacteriologically positive leprosy cases. Koticha KK; Nair PR; Juwatkar PS Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):330-4. PubMed ID: 6890538 [TBL] [Abstract][Full Text] [Related]
36. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505 [TBL] [Abstract][Full Text] [Related]
37. Dapsone in wheat flour as a possible method of therapy in leprosy. A laboratory report. Naik SS; Pandya SS Lepr India; 1977 Oct; 49(4):516-20. PubMed ID: 604659 [No Abstract] [Full Text] [Related]
38. [A new plan in the campaign against leprosy in Anjouan. Preliminary results]. Grillone S; Pattyn SR Acta Leprol; 1986; 4(4):453-60. PubMed ID: 3296616 [TBL] [Abstract][Full Text] [Related]
39. Epidemiology of leprosy in relation to control (WHO technical report series no. 716 of 1985). Part I. Dharmendra Indian J Lepr; 1985; 57(4):699-715. PubMed ID: 3938985 [No Abstract] [Full Text] [Related]
40. Leprosy eradication project of Malta. First published report after 5 years running. Freerksen E; Rosenfeld M Chemotherapy; 1977; 23(5):356-86. PubMed ID: 332467 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]